Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Conduit Pharmaceuticals Inc. - Common Stock (NQ:CDT)

2.000 -0.100 (-4.76%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Conduit Pharmaceuticals Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy
From Conduit Pharmaceuticals
Via GlobeNewswire
Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries
From Conduit Pharmaceuticals
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Conduit Pharmaceuticals Enters Development Agreement With Manoira To Test Drugs In Animals: Retail Sees Stock Above $10
Manoira will initially focus on the evaluation of AZD1656 in animal Osteoarthritis. 
Via Stocktwits
Topics Intellectual Property
Which stocks are experiencing notable movement on Wednesday?
Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
Wednesday's session: gap up and gap down stocks
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health
From Conduit Pharmaceuticals
Via GlobeNewswire
Tuesday's pre-market session: top gainers and losers
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market
From Conduit Pharmaceuticals
Via GlobeNewswire
Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance
From Conduit Pharmaceuticals
Via GlobeNewswire
Conduit Pharma Stock Drops On Reverse Stock Split Announcement: Retail’s Pessimistic
The company said that the reverse stock split will become effective on May 19 at 5:00 p.m. ET, and the stock will start trading on a reverse stock-split adjusted basis at market open on May 20. 
Via Stocktwits
Topics Government
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
From Conduit Pharmaceuticals
Via GlobeNewswire
Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
From Conduit Pharmaceuticals
Via GlobeNewswire
Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset
From Conduit Pharmaceuticals
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
There are notable gap-ups and gap-downs in today's session.
Traders are paying attention to the gapping stocks in Thursday's session. Let's dive into which stocks are experiencing notable gaps. 
Via Chartmill
Conduit Pharmaceuticals Announces Leadership Changes
From Conduit Pharmaceuticals
Via GlobeNewswire
What's Going On With Conduit Pharmaceuticals Shares Friday?
Conduit shares are trading higher after the company announced it filed multiple patents related to VTAMA (tapinarof). 
Via Benzinga
Topics Intellectual Property
Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects
From Conduit Pharmaceuticals
Via GlobeNewswire
Wondering what's happening in today's after-hours session?
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
Top stock movements in today's session.
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
Top movers analysis in the middle of the day on 2025-04-10: top gainers and losers in today's session.
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program
From Conduit Pharmaceuticals
Via GlobeNewswire
Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization
From Conduit Pharmaceuticals
Via GlobeNewswire
Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
From Conduit Pharmaceuticals
Via GlobeNewswire
Wondering what's happening in today's after-hours session?
As the regular session of the US market concludes on Friday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904
From Conduit Pharmaceuticals
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.